---
title: MetLife (MET) — intrinsic value and fair price
canonical: https://sweetvaluelab.com/stocks/met
ticker: MET
as_of: 2026-10-17
sector: Financial Services
industry: Insurance - Life
---
# MetLife (MET)

MetLife (MET) closed at $100.76 on Oct 16, 2026, overvalued by 112% vs its model value of $47.43 (from the justified price to book).

## Key figures

| Figure | Value |
| --- | ---: |
| Last close | $100.76 (Oct 16, 2026) |
| Model value (from the justified price to book) | $47.43 |
| Price vs model | overvalued by 112% vs model |
| Range of that model | $41.50 – $55.33 |
| Market value | $64.0B |
| P/E (fiscal 2025) | 21.4 |
| Net margin (fiscal 2025) | 4.4% |
| Free cash flow (fiscal 2025) | — |
| Dividend yield (trailing twelve months) | 2.30% |
| Beta | 0.78 |
| Cost of capital (WACC) | 7.69% |
| Business classification | Dividend Payer (Low/slowing growth (~5% recent), High profitability (139% net margin), Pays dividends, Highly cyclical earnings) |

## On the stock lists

| List | Place | Figure | Page |
| --- | ---: | ---: | --- |
| Near 52-week highs | #10 | 0.0% | https://sweetvaluelab.com/lists/near-52-week-highs |

## Dividends

| Figure | Value |
| --- | ---: |
| Trailing dividend yield | 2.30% |
| Dividends per share, last 12 months | $2.32 |
| Dividends / earnings (fiscal 2025) | 44.7% |
| Raised | 12 years in a row |
| Growth over 5 years | 4.3% a year |
| Latest payment | $0.5925, ex-date Aug 4, 2026, paid Sep 8, 2026 |

| Year of payments | Dividends per share |
| --- | ---: |
| To Aug 9, 2021 | $1.88 |
| To Aug 8, 2022 | $1.96 |
| To Aug 7, 2023 | $2.04 |
| To Aug 6, 2024 | $2.13 |
| To Aug 5, 2025 | $2.23 |
| Trailing twelve months (to Aug 4, 2026) | $2.32 |

## Valuation models

Each model's value per share and the role the engine gave it for this business. The headline above is one model's value; every other model is listed with its own, and each has a page of its own under the valuation. Computed Oct 17, 2026.

| Model | Role | Value per share | Low | High |
| --- | --- | ---: | ---: | ---: |
| P/B · justified | primary | $47.43 | $41.50 | $55.33 |
| P/E · peers | cross check | $106.46 | $82.96 | $131.54 |
| P/E · own history | cross check | $124.72 | $91.73 | $167.41 |
| PEG | sanity check | $255.73 | $255.73 | $255.73 |
| Dividend discount | cross check | $46.03 | $31.73 | $75.15 |

## Insider activity (SEC Form 4)

No open-market insider buys or sales filed in the past 90 days.

| Date | Insider | Relationship | Transaction | Shares | Value |
| --- | --- | --- | --- | ---: | ---: |
| Oct 1, 2026 | Johnson Jeh C. | Director | Grant / award | 544 | $51,326.4 |
| Oct 1, 2026 | HUBBARD ROBERT GLENN | Director | Grant / award | 941 | $88,783.3 |
| Oct 1, 2026 | Mumenthaler Christian Stephane | Director | Grant / award | 544 | $51,326.4 |
| Oct 1, 2026 | Harris Carla A | Director | Grant / award | 544 | $51,326.4 |
| Oct 1, 2026 | WEINBERGER MARK A | Director | Grant / award | 544 | $0 |

## Recent SEC filings

| Filed | Form | What | Filing |
| --- | --- | --- | --- |
| Sep 24, 2026 | 8-K | 7.01 Regulation FD Disclosure | https://www.sec.gov/Archives/edgar/data/1099219/000109921926000055/met-20260924.htm |
| Aug 17, 2026 | 8-K | 8.01 Other Events; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/1099219/000109921926000052/met-20260817.htm |
| Aug 6, 2026 | 10-Q | Quarterly report | https://www.sec.gov/Archives/edgar/data/1099219/000109921926000050/met-20260630.htm |
| Aug 5, 2026 | 8-K | 2.02 Results of Operations (Earnings); 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/1099219/000109921926000048/met-20260805.htm |
| Jun 29, 2026 | 8-K | 7.01 Regulation FD Disclosure | https://www.sec.gov/Archives/edgar/data/1099219/000109921926000045/met-20260629.htm |

## Superinvestors holding it (latest 13F)

| Manager | Quarter | Shares | Value |
| --- | --- | ---: | ---: |
| Dodge & Cox | 2026-06-30 | 48,431,150 | $4.1B |
| Richard Pzena | 2026-06-30 | 11,130,983 | $941.8M |
| Bridgewater | 2026-06-30 | 621,519 | $52.6M |

3 tracked managers in all.

## About

MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension r…

---

Source: https://sweetvaluelab.com/stocks/met (SweetValueLab, free, no account). Prices and statements from Financial Modeling Prep; filings from SEC EDGAR. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.